Filing Flows

Filing Flows › Clover Health Investments (CLOV) › Q1 2025

Clover Health Investments (CLOV) Q1 2025 earnings results (first quarter 2025)

10-Q filed May 9, 2025

Clover Health Investments (CLOV) reported revenue of $462M for the first quarter 2025 (Q1 2025), +33% from a year earlier and +37% from the quarter before. Operating margin was -0.3%, net loss $1.3M (0.3% of revenue).

Revenue$462M
Year over year+33%
Quarter over quarter+37%
Operating margin-0.3%
Net earnings−$1.3M

Clover Health Investments, Q1 2025: revenue $462M (+33% year over year), operating margin -0.3%, net loss $1.3M, operating cash flow −$16.3M. The chart follows the revenue to costs, profit and cash.

Q1 2025AmountQ/QY/Y
Revenue$462M+37%+33%
Operating profit−$1.3M——
Net earnings−$1.3M——
Operating cash flow−$16.3M——

What changed

Revenue was $462.3M in Q1 2025, up 33% year over year and up 37% from the previous quarter.

Operating costs exceeded revenue by $1.3M, an operating margin of -0.3%. The fastest-growing cost line was Other operating costs (+589%). The quarter ended with a net loss of $1.3M, narrower than the previous quarter's $22.1M loss.

Operating cash flow was −$16.3M. Non-cash charges added back $26.4M of share-based compensation. Working capital and other items used $41.5M. Capital expenditures of $185K exceeded it, leaving free cash flow of −$16.5M.

Questions

What was Clover Health Investments' revenue in the first quarter 2025?

Clover Health Investments (CLOV) reported revenue of $462M for the first quarter 2025 (Q1 2025), +33% from a year earlier and +37% from the quarter before.

Was Clover Health Investments profitable in the first quarter 2025?

Operating loss was $1.3M (-0.3% of revenue) and net loss $1.3M.

Open the interactive Sankey →

Source: Clover Health Investments 10-Q on SEC EDGAR.